Bruce Jackson
Stock Analyst at Benchmark
(1.12)
# 3,488
Out of 4,784 analysts
123
Total ratings
31.09%
Success rate
-19.72%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLTE Belite Bio | Reiterates: Buy | $80 | $66.70 | +19.94% | 9 | Mar 26, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $5.5 → $4.5 | $0.61 | +637.70% | 5 | Mar 24, 2025 | |
| HUMA Humacyte | Reiterates: Buy | n/a | $1.96 | - | 14 | Feb 27, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $9.62 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $43.66 | +48.88% | 7 | Jan 13, 2025 | |
| CLNN Clene | Maintains: Buy | $90 → $84 | $3.22 | +2,508.70% | 7 | Nov 22, 2024 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.55 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $3 | $0.61 | +388.60% | 8 | Nov 22, 2024 | |
| MLSS Milestone Scientific | Reiterates: Speculative Buy | $1.25 | $0.99 | +26.26% | 2 | Nov 20, 2024 | |
| BFRI Biofrontera | Reiterates: Buy | $7 | $0.81 | +761.01% | 7 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.03 | +191.26% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.25 | +122.22% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $1.97 | +1,422.84% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $2 | $0.38 | +426.59% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $1.01 | +1,583.17% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $2.47 | +871.66% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $25 | $3.08 | +711.69% | 6 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $0.73 | +37.01% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $3.21 | +55.76% | 5 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.10 | +354.55% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.32 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.79 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.96 | +26,927.03% | 1 | Aug 8, 2022 |
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $66.70
Upside: +19.94%
Harvard Bioscience
Mar 24, 2025
Maintains: Speculative Buy
Price Target: $5.5 → $4.5
Current: $0.61
Upside: +637.70%
Humacyte
Feb 27, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.96
Upside: -
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.62
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $43.66
Upside: +48.88%
Clene
Nov 22, 2024
Maintains: Buy
Price Target: $90 → $84
Current: $3.22
Upside: +2,508.70%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.55
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.61
Upside: +388.60%
Milestone Scientific
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.99
Upside: +26.26%
Biofrontera
Nov 15, 2024
Reiterates: Buy
Price Target: $7
Current: $0.81
Upside: +761.01%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.03
Upside: +191.26%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.25
Upside: +122.22%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $1.97
Upside: +1,422.84%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $2
Current: $0.38
Upside: +426.59%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $1.01
Upside: +1,583.17%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $2.47
Upside: +871.66%
Jun 3, 2024
Reiterates: Speculative Buy
Price Target: $25
Current: $3.08
Upside: +711.69%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $0.73
Upside: +37.01%
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $3.21
Upside: +55.76%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.10
Upside: +354.55%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.32
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $17.79
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.96
Upside: +26,927.03%